Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06228703 · ClinicalTrials.gov registry record · NA
The Effects of Different Flow Settings on Lung Impedance
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT06228703 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT06228703, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This prospective, randomized crossover trial will enroll adult healthy volunteers. Initially, the subject's peak inspiratory flow will be measured using a mask connected with a respiratory monitor. Subsequently, the volunteers will undergo HFNC treatment at different flow settings while their peak inspiratory flow will be continuously monitored. The primary outcome of this study is the lung aeration with different flow settings. Secondary outcomes include the lung aeration with different devices, subject's comfort at different flow settings, and the correlation between the subject's peak inspiratory flow measured by HFNC and by a mask connected with a respiratory monitor.
Interventions
- DEVICE High-flow nasal cannula device with flow setting at 40 L/min or higher
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-05-19 |
| Est. Completion | 2024-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06228703
The ClinicalTrials.gov registry entry for NCT06228703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High-flow nasal cannula device with flow setting at 40 L/min or higher is the first listed.
NCT06228703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06228703 about?
NCT06228703 is a clinical study titled "The Effects of Different Flow Settings on Lung Impedance". This prospective, randomized crossover trial will enroll adult healthy volunteers. Initially, the subject's peak inspiratory flow will be measured using a mask connected with a respiratory monitor. Subsequently, the volunteers will undergo HFNC treatment at different flow settings while their peak i...
What is the current status of trial NCT06228703?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2024-05-19. Estimated completion is 2024-10-26.
What interventions are being tested in trial NCT06228703?
The interventions under investigation include: High-flow nasal cannula device with flow setting at 40 L/min or higher (DEVICE).
Who is sponsoring clinical trial NCT06228703?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.